Novovax downgraded at JP Morgan and Wedbush on disappointing late-stage trial results
September 16, 2016 at 07:55 AM EDT
The company’s vaccine missed primary and secondary endpoints.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.